D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer’s disease.

For your business

Preclinical data suggest D-chiro-inositol may support brain insulin signaling and reduce amyloid load; worth monitoring for translational relevance.